Therapeutic Recommendations for Nephroblastoma (GFANEPHRO20)
Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.
Sponsor: French Africa Pediatric Oncology Group
Listed as NCT04423484, this observational or N/A phase trial focuses on Nephroblastoma and remains actively recruiting participants. Sponsored by French Africa Pediatric Oncology Group, it has been updated 14 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Mar 2026 — Present [monthly]
Recruiting
-
Nov 2025 — Mar 2026 [monthly]
Recruiting
-
Sep 2025 — Nov 2025 [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 9 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Oct 2023 [monthly]
Recruiting
-
Nov 2021 — Sep 2022 [monthly]
Recruiting
-
Sep 2021 — Nov 2021 [monthly]
Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Recruiting
-
Feb 2021 — Jun 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- French Africa Pediatric Oncology Group
For direct contact, visit the study record on ClinicalTrials.gov .